{"id":"viaject-7","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hypoglycemia"}]},"_chembl":{"chemblId":"CHEMBL1230575","moleculeType":"Small molecule","molecularWeight":"649.02"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by mimicking the action of natural insulin in the body, helping to lower blood sugar levels. This is achieved through the binding of insulin to its receptor, which triggers a cascade of downstream effects that ultimately lead to the uptake of glucose by cells.","oneSentence":"Viaject 7 is a recombinant human insulin analog.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:40:30.000Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diabetes treatment"}]},"trialDetails":[{"nctId":"NCT05062785","phase":"PHASE1","title":"Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants","status":"COMPLETED","sponsor":"Robert Silbergleit","startDate":"2021-10-04","conditions":"Out-Of-Hospital Cardiac Arrest, Healthy","enrollment":24},{"nctId":"NCT05610800","phase":"PHASE2","title":"Exenatide for Smoking Cessation and Prevention of Weight Gain","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-12-07","conditions":"Smoking Cessation, Weight Gain","enrollment":140},{"nctId":"NCT06762314","phase":"PHASE2","title":"Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2025-01-20","conditions":"Diabetes","enrollment":105},{"nctId":"NCT07408141","phase":"","title":"MiniMed Fit Payload Wear Study","status":"RECRUITING","sponsor":"Medtronic Diabetes","startDate":"2026-02-19","conditions":"Diabetes (Insulin-requiring, Type 1 or Type 2)","enrollment":175},{"nctId":"NCT06872333","phase":"PHASE2","title":"Allo HSCT for High Risk Hemoglobinopathies","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-11-19","conditions":"Graft Failure, Sickle Cell Disease, Hemoglobinopathies","enrollment":62},{"nctId":"NCT06693115","phase":"NA","title":"Continuous Glucose Monitoring Using a New Subcutaneous Insulin Protocol for Mild to Moderate Diabetic Ketoacidosis","status":"WITHDRAWN","sponsor":"HealthPartners Institute","startDate":"2026-01","conditions":"Diabetic Ketoacidosis, Hyperglycemia","enrollment":""},{"nctId":"NCT05799781","phase":"NA","title":"Two Way Crossover Closed Loop MPC vs Control IQ","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2023-03-13","conditions":"Type 1 Diabetes","enrollment":29},{"nctId":"NCT07258394","phase":"PHASE3","title":"Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus","status":"RECRUITING","sponsor":"Nanjing Medical University","startDate":"2026-01-27","conditions":"Type 1 Diabetes","enrollment":90},{"nctId":"NCT04876079","phase":"NA","title":"Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2021-06-01","conditions":"Type 1 Diabetes","enrollment":30},{"nctId":"NCT00743782","phase":"PHASE2","title":"Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2008-08-22","conditions":"Hypoparathyroidism, Hypocalcemia, Autoimmune Polyendocrine Syndrome Type 1","enrollment":21},{"nctId":"NCT03624062","phase":"PHASE1","title":"MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2020-08-31","conditions":"Type 1 Diabetes Mellitus","enrollment":21},{"nctId":"NCT07403604","phase":"PHASE1","title":"Effect of Insulin Lowering on Lipogenesis","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-04","conditions":"Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease","enrollment":25},{"nctId":"NCT07224334","phase":"PHASE1","title":"Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.","status":"RECRUITING","sponsor":"David D'Alessio, M.D.","startDate":"2025-12-30","conditions":"Diabetes (DM)","enrollment":30},{"nctId":"NCT07389837","phase":"NA","title":"Maple Syrup Carbohydrate Dose-Response on 20-km Cycling Time-Trial Performance","status":"NOT_YET_RECRUITING","sponsor":"Université de Montréal","startDate":"2026-02-01","conditions":"Exercise, Endurance Cycling Performance, Carbohydrate Intolerance","enrollment":32},{"nctId":"NCT07359625","phase":"NA","title":"Effects of Ketone Bodies on Insulin Sensitivity","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2025-12-02","conditions":"Insulin Resistance, Obesity & Overweight, Energy Metabolism","enrollment":10},{"nctId":"NCT07307677","phase":"NA","title":"Melatonin & Metformin on Clinical & Biochemical Parameters in Insulin Resistant PCOS Compared to Metformin","status":"RECRUITING","sponsor":"Mst.Sumyara Khatun","startDate":"2025-03-11","conditions":"PCOS(Insulin Resistant)","enrollment":60},{"nctId":"NCT07317856","phase":"NA","title":"Efficacy of Microneedling With Hyaluronic Acid Injection for Gingival Augmentation in Thin Gingival Phenotype","status":"NOT_YET_RECRUITING","sponsor":"University of Baghdad","startDate":"2026-01","conditions":"Thin Gingival Biotype","enrollment":20},{"nctId":"NCT07311759","phase":"PHASE3","title":"Safety and Efficacy of Intralesional 0.5% Triamcinolone Acetonide in 0.2% Fluconazole Solution vs 0.1% Topical Mometasone Furoate With 2% Miconazole Nitrate Cream in the Treatment of Chronic Paronychia: An Intraindividual Randomized Controlled Trial.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2024-08-17","conditions":"Chronic Paronychia","enrollment":21},{"nctId":"NCT07298304","phase":"NA","title":"Impact of Sorghum Rice on Beta-Cell Function and Insulin Resistance in Prediabetes","status":"COMPLETED","sponsor":"Dr. Soetomo General Hospital","startDate":"2022-03-01","conditions":"Prediabetic State, Glucose Intolerance, Insulin Resistance","enrollment":26},{"nctId":"NCT05220917","phase":"","title":"Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-08-01","conditions":"Cardiovascular Events, Type2 Diabetes, Renal Disease","enrollment":781430},{"nctId":"NCT06776094","phase":"NA","title":"Physical Activity and Insulin Sensitivity Dynamics","status":"RECRUITING","sponsor":"University of Copenhagen","startDate":"2025-05-05","conditions":"Insulin Sensitivity","enrollment":8},{"nctId":"NCT05454176","phase":"PHASE4","title":"Diabetes in African Youth","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2022-08-15","conditions":"type1diabetes","enrollment":180},{"nctId":"NCT05206877","phase":"PHASE1","title":"Topical Insulin for Glaucoma","status":"RECRUITING","sponsor":"Stanford University","startDate":"2022-04-01","conditions":"Glaucoma","enrollment":52},{"nctId":"NCT05893797","phase":"NA","title":"A Study of LY8888AX in Participants Using a Connected Insulin Management Platform","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2023-10-05","conditions":"Type 1 Diabetes, Type 2 Diabetes, Type 2 Diabetes Treated With Insulin","enrollment":36},{"nctId":"NCT06221852","phase":"NA","title":"Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder","status":"RECRUITING","sponsor":"Mclean Hospital","startDate":"2024-03-12","conditions":"Bipolar I Disorder, Psychosis, Schizoaffective Disorder","enrollment":50},{"nctId":"NCT06490874","phase":"","title":"Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT","status":"WITHDRAWN","sponsor":"Ohio State University","startDate":"2025-09","conditions":"Gestational Diabetes Mellitus, Pregnancy, High Risk","enrollment":""},{"nctId":"NCT06411548","phase":"NA","title":"InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2025-03-27","conditions":"Type 1 Diabetes Mellitus","enrollment":7},{"nctId":"NCT07201155","phase":"","title":"The Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients","status":"COMPLETED","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2024-05-01","conditions":"Hyperglycemia in Critically Ill Patients","enrollment":55},{"nctId":"NCT05353322","phase":"NA","title":"Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health","status":"RECRUITING","sponsor":"Columbia University","startDate":"2022-06-30","conditions":"Sedentary Behavior, Cardiometabolic Risk Factors, Blood Pressure","enrollment":324},{"nctId":"NCT03608163","phase":"PHASE4","title":"Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)","status":"TERMINATED","sponsor":"Albert Einstein College of Medicine","startDate":"2019-01-08","conditions":"Diabetes Mellitus, Type 1, Hypoglycemia, Hypoglycemia Unawareness","enrollment":4},{"nctId":"NCT07146347","phase":"PHASE1","title":"Comparison Study of Insulin GZR4 With Insulin Degludec","status":"RECRUITING","sponsor":"Gan and Lee Pharmaceuticals, USA","startDate":"2025-08-15","conditions":"Type 2 Diabetes","enrollment":14},{"nctId":"NCT06472011","phase":"NA","title":"Effects of Common Meals on Appetite and Satiety","status":"COMPLETED","sponsor":"San Diego State University","startDate":"2024-08-07","conditions":"Healthy","enrollment":20},{"nctId":"NCT07131384","phase":"NA","title":"Interaction Between Inorganic Nitrate Supplementation and Metformin in Individuals With Prediabetes","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2025-09-01","conditions":"Males, Females, Sedentary","enrollment":24},{"nctId":"NCT06633965","phase":"NA","title":"Safety and Feasibility Testing of a Smaller Network Version of AIDANET","status":"COMPLETED","sponsor":"Marc Breton","startDate":"2024-11-20","conditions":"Type 1 Diabetes","enrollment":8},{"nctId":"NCT03841981","phase":"","title":"Body Fat as Determinant of Female Gonadal Dysfunction","status":"RECRUITING","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2020-01-31","conditions":"Polycystic Ovary Syndrome, Hypothalamic Amenorrhea","enrollment":50},{"nctId":"NCT07109245","phase":"PHASE4","title":"Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?","status":"NOT_YET_RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2025-09-01","conditions":"Brain Insulin Sensitivity, Healthy Controls, Cognition","enrollment":35},{"nctId":"NCT07103083","phase":"NA","title":"Postprandial Response to Fruit Juice","status":"RECRUITING","sponsor":"Ocean Spray Cranberries, Inc.","startDate":"2025-07-21","conditions":"Blood Glucose, Blood Insulin","enrollment":18},{"nctId":"NCT04062890","phase":"PHASE2","title":"Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance","status":"WITHDRAWN","sponsor":"University of Arizona","startDate":"2030-04-15","conditions":"Hyperinsulinism, Insulin Resistance, Insulin Sensitivity","enrollment":""},{"nctId":"NCT04300790","phase":"PHASE2","title":"Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients","status":"COMPLETED","sponsor":"MedSIR","startDate":"2020-10-23","conditions":"Breast Cancer","enrollment":69},{"nctId":"NCT06458946","phase":"NA","title":"Monitoring Postprandial Blood Glucose and Insulin in Fruit Snacks","status":"COMPLETED","sponsor":"Ocean Spray Cranberries, Inc.","startDate":"2024-05-22","conditions":"Blood Glucose, Blood Insulin","enrollment":24},{"nctId":"NCT01047735","phase":"NA","title":"The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2009-09-01","conditions":"Type 2 Diabetes Mellitus, Obesity","enrollment":69},{"nctId":"NCT07049601","phase":"NA","title":"THE Effect of Tight Glycemic Control on Microvascular Complications in Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-05-11","conditions":"Diabetes Mellitus","enrollment":80},{"nctId":"NCT04088981","phase":"NA","title":"Effect of a Dietary Intervention on Intracellular Lipid Levels, Insulin Sensitivity, and Glycemic Control in Type 2 Diabetes","status":"WITHDRAWN","sponsor":"Physicians Committee for Responsible Medicine","startDate":"2025-07","conditions":"Diabetes Mellitus, Type 2","enrollment":""},{"nctId":"NCT03492580","phase":"","title":"A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-02-22","conditions":"Diabetes Mellitus, Type 2, Cardiovascular Diseases","enrollment":714582},{"nctId":"NCT05224258","phase":"NA","title":"Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®","status":"COMPLETED","sponsor":"Medtronic Diabetes","startDate":"2022-03-17","conditions":"Type 1 Diabetes","enrollment":240},{"nctId":"NCT06412497","phase":"PHASE2","title":"MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-06-05","conditions":"Severe Aplastic Anemia, Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia","enrollment":60},{"nctId":"NCT03566511","phase":"PHASE2","title":"Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide","status":"TERMINATED","sponsor":"Meredith Hawkins","startDate":"2018-06-12","conditions":"Diabetes Mellitus, Type 2, Glucose, High Blood, Glucose Metabolism Disorders (Including Diabetes Mellitus)","enrollment":37},{"nctId":"NCT06443814","phase":"PHASE2","title":"Multicenter Trial of Meditation and Health Education for Cardiometabolic Disease in Black Women","status":"COMPLETED","sponsor":"Robert Schneider, MD","startDate":"2001-07","conditions":"Atherosclerotic Cardiovascular Disease, Metabolic Syndrome","enrollment":201},{"nctId":"NCT06728059","phase":"NA","title":"Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm","status":"RECRUITING","sponsor":"Sue Brown","startDate":"2025-02-05","conditions":"Type 1 Diabetes","enrollment":16},{"nctId":"NCT02646475","phase":"PHASE1","title":"Metabolic Effects of Angiotensin-(1-7)","status":"RECRUITING","sponsor":"Vanderbilt University","startDate":"2016-02","conditions":"Obesity, Insulin Resistance, Hypertension","enrollment":26},{"nctId":"NCT04267705","phase":"NA","title":"Pulses Consumption and Its Role in Managing Systemic Inflammation, Insulin Sensitivity and Gut Microbiome in Human","status":"ACTIVE_NOT_RECRUITING","sponsor":"Clinical Nutrition Research Center, Illinois Institute of Technology","startDate":"2020-02-24","conditions":"Insulin Sensitivity, Overweight or Obesity, Inflammatory Response","enrollment":103},{"nctId":"NCT05040087","phase":"NA","title":"Changing the Natural History of Type 2 Diabetes (\"CHANGE\" Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Foundation for Atlanta Veterans Education and Research, Inc.","startDate":"2021-09-01","conditions":"Type 2 Diabetes","enrollment":127},{"nctId":"NCT03987308","phase":"NA","title":"Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients","status":"RECRUITING","sponsor":"Beijing Hospital","startDate":"2019-07-02","conditions":"Type 2 Diabetic Patients, T2DM (Type 2 Diabetes Mellitus), T2DM","enrollment":115},{"nctId":"NCT06424652","phase":"NA","title":"Effect of Physiologic Insulin Administration on Cognition","status":"COMPLETED","sponsor":"Pennington Biomedical Research Center","startDate":"2024-05-16","conditions":"Alzheimer Disease","enrollment":1},{"nctId":"NCT05361148","phase":"","title":"Long-term Health After Severe Acute Malnutrition in Children and Adults: the Role of the Pancreas","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2021-01-12","conditions":"Pancreas Atrophy, Diabetes, Malnutrition","enrollment":2305},{"nctId":"NCT06558201","phase":"NA","title":"Open Label Extension Study of NCT06221852","status":"ENROLLING_BY_INVITATION","sponsor":"Mclean Hospital","startDate":"2024-08-28","conditions":"Bipolar I Disorder, Schizoaffective Disorder, Psychosis","enrollment":50},{"nctId":"NCT06283797","phase":"NA","title":"Efficacy of Automated Insulin Therapy Early Initiated After Diagnosis on Blood Glucose Control in Children and Adolescents With Type 1 Diabetes","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2024-05-29","conditions":"Diabetes","enrollment":112},{"nctId":"NCT03540758","phase":"PHASE2","title":"Regulation of Endogenous Glucose Production by Central KATP Channels","status":"RECRUITING","sponsor":"Meredith Hawkins","startDate":"2018-08-01","conditions":"Type 2 Diabetes Mellitus, Glucose Metabolism Disorders, Glucose, High Blood","enrollment":100},{"nctId":"NCT02583763","phase":"","title":"Cardiac Displacement From Third Trimester to Early Childhood","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Linkoeping","startDate":"2013-01","conditions":"IUGR, Fetal Growth Retardation, Intrauterine Growth Restriction","enrollment":61},{"nctId":"NCT03784027","phase":"NA","title":"The Artificial Pancreas in Very Young Children With T1D","status":"COMPLETED","sponsor":"University of Cambridge","startDate":"2019-05-01","conditions":"Type 1 Diabetes Mellitus","enrollment":81},{"nctId":"NCT06656377","phase":"NA","title":"Optimization of Exercise Protocol for Prediabetic Population in Postprandial State","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2022-09-15","conditions":"Prediabetes, Exercise, Blood Glucose Profile","enrollment":25},{"nctId":"NCT06848933","phase":"NA","title":"Could the Advanced Hybrid Closed-Loop System Algorithm Provide Postprandial Normoglycemia After a High-Fat, High-Protein Meal","status":"COMPLETED","sponsor":"Ege University","startDate":"2024-01-05","conditions":"Type 1 Diabetes Mellitus, Adolescents","enrollment":20},{"nctId":"NCT05306028","phase":"PHASE2","title":"Metformin and Insulin to Pancreatic Cancer Related Diabetes (Type 3c)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fudan University","startDate":"2022-08-01","conditions":"Pancretic Cancer, Diabete Mellitus","enrollment":20},{"nctId":"NCT06810596","phase":"NA","title":"Comparing Efficacy Between Two Protocols of Intravenous Insulin Infusion for Diabetic Adults in ICU","status":"RECRUITING","sponsor":"Suez Canal University","startDate":"2024-12-15","conditions":"Glycemic Control, Critical Care, Diabetes Mellitus","enrollment":100},{"nctId":"NCT05368402","phase":"PHASE2","title":"Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.","status":"TERMINATED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2022-09-14","conditions":"Type 1 Diabetes","enrollment":3},{"nctId":"NCT06273241","phase":"NA","title":"Impact of Food Intake on Berberine Kinetics","status":"COMPLETED","sponsor":"University Medicine Greifswald","startDate":"2024-03-04","conditions":"Pharmacokinetic Study in Healthy Volunteers","enrollment":12},{"nctId":"NCT05325294","phase":"NA","title":"Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®","status":"COMPLETED","sponsor":"Medtronic Diabetes","startDate":"2022-05-05","conditions":"Type 1 Diabetes","enrollment":244},{"nctId":"NCT06774105","phase":"NA","title":"Stretching and Diabetes","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2024-06-01","conditions":"Type 1 Diabetes (T1D)","enrollment":27},{"nctId":"NCT04321395","phase":"PHASE2","title":"Vigabatrin and Insulin Sensitivity","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2021-08-23","conditions":"NAFLD, Obesity","enrollment":4},{"nctId":"NCT03959423","phase":"NA","title":"Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System","status":"COMPLETED","sponsor":"Medtronic Diabetes","startDate":"2019-07-24","conditions":"Type 1 Diabetes Mellitus","enrollment":288},{"nctId":"NCT05384431","phase":"PHASE3","title":"Can We Achieve 'high-quality' Weight Loss Through Supplementation and Exercise? the TRIM MUSCLE Study","status":"COMPLETED","sponsor":"Exerkine Corporation","startDate":"2022-08-15","conditions":"Overweight, Obesity","enrollment":51},{"nctId":"NCT06601660","phase":"NA","title":"Metabolic Investigation, Physical Performance, Physical Training At Different Times of the Day in Obese Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"State University of Minas Gerais","startDate":"2024-09-16","conditions":"Obesity Type I and II, Obesity and Overweight","enrollment":60},{"nctId":"NCT04113122","phase":"NA","title":"Senescence and the Early Ageing Phenotype After Chemotherapy for Testicular Cancer: the SEA-CAT Study","status":"RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2019-02-09","conditions":"Testicular Cancer","enrollment":192},{"nctId":"NCT02844907","phase":"PHASE4","title":"Regulation of Insulin Secretion by the GLP-1 Receptor","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2018-07-01","conditions":"Insulin Secretion","enrollment":6},{"nctId":"NCT04025762","phase":"NA","title":"24/7 Closed-loop in Older Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Cambridge","startDate":"2019-09-01","conditions":"Type 1 Diabetes Mellitus, Hypoglycemia, Arrythmia","enrollment":38},{"nctId":"NCT04114903","phase":"","title":"Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity","status":"COMPLETED","sponsor":"University of Colorado, Boulder","startDate":"2019-11-08","conditions":"Type 2 Diabetes, Obesity, Cannabis Use","enrollment":255},{"nctId":"NCT03354390","phase":"PHASE1","title":"HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2018-07-20","conditions":"Kidney Cancer","enrollment":17},{"nctId":"NCT06697977","phase":"NA","title":"Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients with Nonalcoholic Fatty Liver Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Jordan","startDate":"2023-08-15","conditions":"NAFLD, Insulin Resistance, Metabolic Syndrome","enrollment":28},{"nctId":"NCT05275608","phase":"NA","title":"Effects of VLCKD in Metabolic Syndrome","status":"RECRUITING","sponsor":"Azienda Ospedaliero Universitaria Maggiore della Carita","startDate":"2022-11-07","conditions":"Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease, Obesity","enrollment":40},{"nctId":"NCT06650943","phase":"NA","title":"Nursing Intervention in Weight and Metabolic Syndrome Management in First-episode Psychosis (MetaKOP)","status":"RECRUITING","sponsor":"Hospital de Basurto","startDate":"2023-10-25","conditions":"First Episode Psychosis (FEP), Metabolic Syndrome X","enrollment":88},{"nctId":"NCT06613854","phase":"PHASE4","title":"Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes","status":"RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2024-10-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":90},{"nctId":"NCT03364868","phase":"PHASE2","title":"GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)","status":"COMPLETED","sponsor":"Technical University of Munich","startDate":"2018-02-07","conditions":"Diabetes Mellitus, Type 1","enrollment":1050},{"nctId":"NCT04944316","phase":"NA","title":"Effect of a Dietary Intervention on Insulin Requirements in Type 1 Diabetes","status":"COMPLETED","sponsor":"Physicians Committee for Responsible Medicine","startDate":"2022-01-19","conditions":"Diabetes Mellitus, Type 1","enrollment":35},{"nctId":"NCT03418779","phase":"PHASE2, PHASE3","title":"Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-07-04","conditions":"IgA Nephropathy at High Risk of Developing ESRD","enrollment":60},{"nctId":"NCT06591208","phase":"NA","title":"Study the Effect of Pulsed Dye Laser Versus Carboxytherapy in the Treatment of Striae Rubra","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2024-09-11","conditions":"Striae Distensae","enrollment":20},{"nctId":"NCT03049306","phase":"PHASE2","title":"Propranolol for Sleep Apnea Therapy","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2017-02-15","conditions":"Obstructive Sleep Apnea","enrollment":24},{"nctId":"NCT06532461","phase":"NA","title":"A Trial of Three- and Seven-days Insulin Infusions Set","status":"RECRUITING","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2024-07-20","conditions":"Type 1 Diabetes","enrollment":80},{"nctId":"NCT02722499","phase":"NA","title":"Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST)","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2016-03","conditions":"Diabetes Mellitus, Type 2 Diabetes Mellitus, Adult-Onset Diabetes Mellitus","enrollment":60},{"nctId":"NCT03298867","phase":"PHASE3","title":"Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study","status":"COMPLETED","sponsor":"Amgen","startDate":"2017-10-04","conditions":"Thyroid Eye Disease, Graves' Orbitopathy","enrollment":83},{"nctId":"NCT06126354","phase":"PHASE1","title":"Dexamethasone/Pancreatic Clamp P&F","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2024-07-01","conditions":"Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease","enrollment":""},{"nctId":"NCT03685123","phase":"NA","title":"Exercise After Clinically Significant Weight Loss","status":"COMPLETED","sponsor":"East Carolina University","startDate":"2019-02-12","conditions":"Obesity, Sedentary Lifestyle, Insulin Resistance","enrollment":39},{"nctId":"NCT06469593","phase":"NA","title":"Automated Insulin Delivery for Type 1 Diabetes - Beyond Glucose Metrics","status":"RECRUITING","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2024-06-15","conditions":"Diabetes Mellitus, Type 1","enrollment":200},{"nctId":"NCT04040894","phase":"","title":"Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease","status":"APPROVED_FOR_MARKETING","sponsor":"Amgen","startDate":"","conditions":"Thyroid Eye Disease, Graves' Orbitopathy","enrollment":""},{"nctId":"NCT06447558","phase":"NA","title":"The Effects of \"Oral Administration of Breast Milk Droplets\" and \"Palatal Stimulation With a Finger\"","status":"COMPLETED","sponsor":"Istanbul Medipol University Hospital","startDate":"2021-05-01","conditions":"Infants","enrollment":90},{"nctId":"NCT02871089","phase":"NA","title":"Closed Loop From Onset in Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cambridge","startDate":"2017-01","conditions":"Diabetes Mellitus, Type 1 Diabetes","enrollment":96},{"nctId":"NCT03437330","phase":"PHASE4","title":"Empagliflozin Effect on Glucose Toxicity","status":"WITHDRAWN","sponsor":"University Hospital Tuebingen","startDate":"2021-10-27","conditions":"Type2 Diabetes Mellitus","enrollment":""},{"nctId":"NCT04909333","phase":"NA","title":"Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-04-29","conditions":"Endogenous Hyperinsulinism","enrollment":29},{"nctId":"NCT04011020","phase":"PHASE2, PHASE3","title":"Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes","status":"RECRUITING","sponsor":"Throne Biotechnologies Inc.","startDate":"2022-09-20","conditions":"Type 1 Diabetes","enrollment":50},{"nctId":"NCT03203694","phase":"NA","title":"Effects of Walking and Heating on Vascular Function in Diabetic Patients","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2017-12-04","conditions":"Type 2 Diabetes Mellitus, Obesity","enrollment":99},{"nctId":"NCT02460783","phase":"NA","title":"Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function","status":"COMPLETED","sponsor":"National Institute on Aging (NIA)","startDate":"2015-06-22","conditions":"Alzheimer's Disease, Obesity, Diabetes Mellitus","enrollment":129}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Viaject 7","genericName":"Viaject 7","companyName":"Biodel","companyId":"biodel","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Viaject 7 is a recombinant human insulin analog. Used for Diabetes treatment.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}